Cyber, OpenAI is taking the next step in the use of generative AI for cybersecurity. While earlier models already ...

OCBC has launched a generative AI training programme in Singapore to improve coaching consistency and advisory skills for ...

Pacvue announced today the launch of Pacvue Agent, the next evolution of its AI Outcome Engine that moves commerce media from analysis ...

As the AI era becomes increasingly shaped by foundation models, the pharmaceutical industry is entering a new phase of opportunity for discovery, design, and decision-making driven by AI for science.

When Tirias Research first forecasted global generative AI demand in 2023, we predicted token output would reach an aggressive 20 trillion tokens, such as a letter, word, or punctuation, by the end of ...

Introduction: Nasdaq Correction and the AI Opportunity The Nasdaq Composite has slipped into a correction phase, prompting investors to reassess ...

The 2026 season of the Pharma.AI webinar series will showcase the ongoing AI revolution in life sciences, including the ...

Introduction: Cloudflare at the Crossroads of Edge Computing and AI In the past two years, the technology landscape has been ...

Spread the loveThe world of cinema is experiencing a seismic shift with the introduction of artificial intelligence in creative processes. A landmark project has emerged featuring an AI-generated ...